Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype Source: Eur Respir J, 51 (2) 1702146; 10.1183/13993003.02146-2017 Year: 2018
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006
The role of peripheral muscle electrical stimulation Source: Annual Congress 2005 - PG7 - New treatment strategies in pulmonary rehabilitation Year: 2005
Mitochondrial functional alterations in COPD locomotor muscle are independent of cachexia and fiber type shift Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014
The effect of corticosteroid use on skeletal muscle function in patients with interstitial lung disease Source: Annual Congress 2012 - The latest insights in integrated care Year: 2012
Resorptive-destructive processes of bone tissue in COPD patients Source: International Congress 2019 – Asthma and COPD comorbidities Year: 2019
A comparison of lung function, respiratory and peripheral muscle strength, and functional capacity in low and high-fatigue patients with COPD Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease Year: 2010
Skeletal muscle histology and functional capacity in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 289s Year: 2002
COPD patients with skeletal muscle dysfunction VS patients without impairment of skeletal muscle. Comparing features of COPD and life quality. Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019
Lung function, respiratory muscle strength, functional capacity, and peripheral muscle endurance between patients with suppurative lung disease and healthy subjects Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing Year: 2008
Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016
Is systemic inflammation the main driver of skeletal muscle weakness during COPD exacerbations (AE)? Source: Eur Respir J 2005; 26: Suppl. 49, 180s Year: 2005
Linking clinical phenotypes of chronic lung allograft dysfunction to changes in lung structure Source: Eur Respir J 2015; 46: 1430-1439 Year: 2015
Effect of pulmonary rehabilitation on peripheral muscle wasting, functional capacity and quality of life in cachectic patients with COPD Source: Annual Congress 2008 - Effects of rehabilitation in very disabled COPD patients Year: 2008
Cardiac muscle mass and function are associated with altered body composition in patients with COPD Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007
Effect of pulmonary rehabilitation on systemic inflammatory markers, muscle cross section area and functional parameters in interstitial lung disease Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012
Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment. Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020
Skeletal muscle stem cells and capillaries; important neighbours in muscle tissue of COPD patients Source: Virtual Congress 2020 – Managing frailty in patients with acute or chronic lung disorders Year: 2020
Beyond the lungs in fibrotic interstitial lung disease: does supplemental O2 improve skeletal muscle oxygenation and fatigue? Source: Virtual Congress 2020 – Exploring respiratory function Year: 2020